<- Go Home

E-Z-EM Inc.

As of April 2, 2008, E-Z-EM Inc. was acquired by Bracco Diagnostics Inc. E-Z-EM Inc. provides medical products used by radiologists, gastroenterologists, and speech-language pathologists in screening for and diagnosing diseases and disorders of the GI tract. The company offers injectors and peripherals, and CT oral contrast for imaging applications; Varibar contrast agents for speech pathology applications; patient preparation, procedure and analysis, and training and marketing resources for virtual colonoscopy applications; and devices, endoscopy accessories, and patient preparation systems for gastroenterology applications. It also provides reactive skin decontamination lotions that break down chemical agents, such as Sarin or VX. The company’s products are used for colorectal cancer screening, evaluation of swallowing disorders/dysphagia, virtual colonoscopy, X-ray fluoroscopy, accessory medical devices, and contract manufacturing. It sells its products to markets in the United States, Europe, and Japan. The company was founded in 1962 and is headquartered in Lake Success, New York.

Market Cap

$232.8M

Volume

46.2K

Cash and Equivalents

$9.9M

EBITDA

$15.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$64.6M

Profit Margin

44.00%

52 Week High

$21.00

52 Week Low

$11.68

Dividend

N/A

Price / Book Value

1.92

Price / Earnings

28.03

Price / Tangible Book Value

1.96

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$12.0M

Return on Equity

7.37%

Return on Assets

5.59

Cash and Short Term Investments

$44.6M

Debt

N/A

Equity

$121.5M

Revenue

$146.8M

Unlevered FCF

-$2.1M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches